A. “Bapineuzumab Alters A{beta} Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy,” by Alex E. Roher, David H. Cribbs, Ronald C. Kim, Chera L. Maarouf, Charisse M. Whiteside, Tyler A. Kokjohn, Ian D. Daugs, Elizabeth Head, Carolyn Liebsack, Geidy Serrano, Christine Belden, Marwan N. Sabbagh, and Thomas G. Beach (PLoS ONE 8(3): e59735. doi:10.1371/journal.pone.0059735, XML, HTML, and .pdf format, 18p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0059735
B. “White Matter Changes in Patients with Amnestic Mild Cognitive Impairment Detected by Diffusion Tensor Imaging,” by Jianghong Liu, Changhao Yin, Shugao Xia, Longfei Jia, Yanqin Guo, Zhilian Zhao, Xiaobo Li, Ying Han, and Jianping Jia (PLoS ONE 8(3): e59440. doi:10.1371/journal.pone.0059440, XML, HTML, and .pdf format, 7p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0059440
